Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating activities
Net income (loss)	$ 126,038	$ (23,546)	$ (65,678)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	17,088	9,515	7,474
Stock-based compensation	92,322	66,080	42,817
Change in fair value of liabilities	0	1,075	(70)
Net (accretion) amortization on securities	(4,355)	(5,686)	146
Benefit for deferred taxes	(61,649)	(13)	(594)
Impairment of long-lived assets	114	429	1,127
Non-cash operating lease cost	2,546	1,922	1,605
Non-cash acquisition-related costs	0	2,691	837
Non-cash other	357	195	0
Changes in operating assets and liabilities:
Inventory	(41,612)	(902)	(8,004)
Prepaid expenses and other current assets	(9,494)	(6,395)	(6,335)
Other long-term assets	(56)	(58)	17
Accounts payable	43,710	7,324	12,723
Accrued liabilities	23,791	16,524	909
Deferred revenue	67,552	6,261	(1,716)
Operating lease liabilities	(2,443)	(1,933)	(1,605)
Earn-out payable	(2,825)	0	(10,184)
Net cash provided by (used in) operating activities	251,084	73,483	(26,531)
Investing activities
Purchases of investments	(160,564)	(157,239)	(187,700)
Maturities of investments	208,940	170,051	194,259
Proceeds from sales of investments	725	1,574	35,846
Investment in website and mobile application development and internal-use software	(11,095)	(9,272)	(4,533)
Purchases of property, equipment, and intangible assets	(41,655)	(17,220)	(2,714)
Acquisition of business, net of cash acquired	(15,399)	0	0
Deferred consideration paid for acquisitions	0	0	(459)
Net cash (used in) provided by investing activities	(19,048)	(12,106)	34,699
Financing activities
Proceeds from exercise of vested stock options	26,651	2,322	2,246
Payments for taxes related to net share settlement of equity awards	(52,501)	(14,096)	(3,901)
Repurchases of common stock	(83,039)	(1,999)	0
Payments for acquisition-related earn-out consideration	(3,190)	0	(32,650)
Proceeds from employee stock purchase plan	3,901	2,298	1,178
Proceeds from exercise of Class A common stock warrants	333	0	0
Net cash used in financing activities	(107,845)	(11,475)	(33,127)
Foreign currency effect on cash and cash equivalents	(270)	(11)	(53)
Increase (decrease) in cash, cash equivalents, and restricted cash	123,921	49,891	(25,012)
Cash, cash equivalents, and restricted cash at beginning of period	97,519	47,628	72,640
Cash, cash equivalents, and restricted cash at end of period	221,440	97,519	47,628
Reconciliation of cash, cash equivalents, and restricted cash
Cash and cash equivalents	220,584	96,663	46,772
Restricted cash	856	856	856
Total cash, cash equivalents, and restricted cash	221,440	97,519	47,628
Supplemental disclosures of cash flow information
Cash paid for taxes	7,916	1,109	636
Non-cash investing and financing activities
Purchases of property and equipment included in accounts payable and accrued liabilities	7,781	3,383	0
Right-of-use asset obtained in exchange for lease liability	2,593	6,270	1,206
Vesting of early exercised stock options	0	0	197
Issuance of common stock for acquisition-related earn-out consideration	1,396	0	0
Issuance of common stock and liabilities assumed in connection with acquisition of business	$ 16,000	$ 0	$ 0